Suppr超能文献

Pyrin 炎症小体在健康与疾病中的作用

The Pyrin Inflammasome in Health and Disease.

机构信息

Metabolic, Cardiovascular and Inflammatory Disease Genomics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, United States.

出版信息

Front Immunol. 2019 Aug 7;10:1745. doi: 10.3389/fimmu.2019.01745. eCollection 2019.

Abstract

The pyrin inflammasome has evolved as an innate immune sensor to detect bacterial toxin-induced Rho guanosine triphosphatase (Rho GTPase)-inactivation, a process that is similar to the "guard" mechanism in plants. Rho GTPases act as molecular switches to regulate a variety of signal transduction pathways including cytoskeletal organization. Pathogens can modulate Rho GTPase activity to suppress host immune responses such as phagocytosis. Pyrin is encoded by , the gene that is mutated in patients with familial Mediterranean fever (FMF). FMF is the prototypic autoinflammatory disease characterized by recurring short episodes of systemic inflammation and is a common disorder in many populations in the Mediterranean basin. Pyrin specifically senses modifications in the activity of the small GTPase RhoA, which binds to many effector proteins including the serine/threonine-protein kinases PKN1 and PKN2 and actin-binding proteins. RhoA activation leads to PKN-mediated phosphorylation-dependent pyrin inhibition. Conversely, pathogen virulence factors downregulate RhoA activity in a variety of ways, and these changes are detected by the pyrin inflammasome irrespective of the type of modifications. pathogenic variants favor the active state of pyrin and elicit proinflammatory cytokine release and pyroptosis. They can be inherited either as a dominant or recessive trait depending on the variant's location and effect on the protein function. Mutations in the C-terminal B30.2 domain are usually considered recessive, although heterozygotes may manifest a biochemical or even a clinical phenotype. These variants are hypomorphic in regard to their effect on intramolecular interactions, but ultimately accentuate pyrin activity. Heterozygous mutations in other domains of pyrin affect residues critical for inhibition or protein oligomerization, and lead to constitutively active inflammasome. In healthy carriers of FMF mutations who have the subclinical inflammatory phenotype, the increased activity of pyrin might have been protective against endemic infections over human history. This finding is supported by the observation of high carrier frequencies of FMF-mutations in multiple populations. The pyrin inflammasome also plays a role in mediating inflammation in other autoinflammatory diseases linked to dysregulation in the actin polymerization pathway. Therefore, the assembly of the pyrin inflammasome is initiated in response to fluctuations in cytoplasmic homeostasis and perturbations in cytoskeletal dynamics.

摘要

pyrin 炎性小体作为先天免疫传感器进化而来,用于检测细菌毒素诱导的 Rho 鸟苷三磷酸酶(Rho GTPase)失活,这一过程类似于植物的“防护”机制。Rho GTPases 作为分子开关,调节包括细胞骨架组织在内的多种信号转导途径。病原体可以调节 Rho GTPase 活性,从而抑制吞噬作用等宿主免疫反应。Pyrin 由 基因编码,该基因突变与家族性地中海热(FMF)患者有关。FMF 是一种典型的自身炎症性疾病,其特征是反复发作的全身炎症短暂发作,是地中海盆地许多人群中的常见疾病。Pyrin 特异性感知小分子 GTPase RhoA 活性的改变,RhoA 与包括丝氨酸/苏氨酸蛋白激酶 PKN1 和 PKN2 以及肌动蛋白结合蛋白在内的许多效应蛋白结合。RhoA 激活导致 PKN 介导的依赖磷酸化的 pyrin 抑制。相反,病原体毒力因子通过多种方式下调 RhoA 活性,而炎性小体检测到这些变化与修饰类型无关。致病性变异有利于 pyrin 的活性状态,并引发促炎细胞因子释放和细胞焦亡。它们可以作为显性或隐性性状遗传,具体取决于变体的位置及其对蛋白功能的影响。C 端 B30.2 结构域的突变通常被认为是隐性的,尽管杂合子可能表现出生化甚至临床表型。这些变体在其对分子内相互作用的影响方面是低功能的,但最终会增强 pyrin 的活性。pyrin 其他结构域的杂合突变影响抑制或蛋白寡聚化的关键残基,导致组成性激活的炎性小体。在具有亚临床炎症表型的 FMF 突变的健康携带者中,pyrin 的活性增加可能在人类历史上对地方性感染具有保护作用。这一发现得到了在多个人群中发现 FMF 突变高携带频率的观察结果的支持。pyrin 炎性小体在其他与肌动蛋白聚合途径失调相关的自身炎症性疾病中也发挥着介导炎症的作用。因此,pyrin 炎性小体的组装是响应细胞质内稳态波动和细胞骨架动力学扰动而启动的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83bd/6698799/03c52bb08dca/fimmu-10-01745-g0001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验